Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.

A National Transcatheter Aortic Valve Replacement registry must ... Patients were required to have severe aortic stenosis defined by either an aortic valve area of less than 0.8 cm2, an aortic ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Coronary events after TAVR are rare but impact survival. PCI improves outcomes, particularly in balloon-expandable valve ...

A high burden of heart valve diseases is driving its expansion. India’s transcatheter aortic valve replacement (TAVR) market ...

Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart condition, common in elderly, restricts blood flow due to valve narrowing, ...

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.

Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its ...

The Heart and Vascular center at Portneuf Medical Center recently marked its 400th transaortic valve replacement procedure.

GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

While the TAVR market is maturing, it is still far from saturated, as recent clinical trial results demonstrated. Many aortic stenosis patients prior to seeking TAVR treatment exhibit adverse ...